Ticagrelor effectiveness overestimated by VASP index: platelet inhibition by ticagrelor versus prasugrel in acute coronary syndrome patients according to platelet function tests.
Dillinger, Jean-Guillaume
Ticagrelor effectiveness overestimated by VASP index: platelet inhibition by ticagrelor versus prasugrel in acute coronary syndrome patients according to platelet function tests. [electronic resource] - International journal of cardiology Sep 2014 - 557-9 p. digital
Publication Type: Comparative Study; Letter
1874-1754
10.1016/j.ijcard.2014.07.019 doi
Acute Coronary Syndrome--blood
Adenosine--analogs & derivatives
Humans
Male
Middle Aged
Piperazines--therapeutic use
Platelet Aggregation Inhibitors--therapeutic use
Platelet Function Tests--methods
Prasugrel Hydrochloride
Prospective Studies
Purinergic P2Y Receptor Antagonists--therapeutic use
Thiophenes--therapeutic use
Ticagrelor
Treatment Outcome
Ticagrelor effectiveness overestimated by VASP index: platelet inhibition by ticagrelor versus prasugrel in acute coronary syndrome patients according to platelet function tests. [electronic resource] - International journal of cardiology Sep 2014 - 557-9 p. digital
Publication Type: Comparative Study; Letter
1874-1754
10.1016/j.ijcard.2014.07.019 doi
Acute Coronary Syndrome--blood
Adenosine--analogs & derivatives
Humans
Male
Middle Aged
Piperazines--therapeutic use
Platelet Aggregation Inhibitors--therapeutic use
Platelet Function Tests--methods
Prasugrel Hydrochloride
Prospective Studies
Purinergic P2Y Receptor Antagonists--therapeutic use
Thiophenes--therapeutic use
Ticagrelor
Treatment Outcome